Higher oxidation and lower antioxidant levels in peripheral blood plasma and bone marrow plasma from advanced cancer patients
✍ Scribed by Elena M. V. de Cavanagh; Alba E. Honegger; Erica Hofer; Raul H. Bordenave; Eduardo O. Bullorsky; Norma A. Chasseing; Cesar Fraga
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 64 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
BACKGROUND
Bone marrow (BM) is an important tissue in the generation of immunocompetent and peripheral blood cells. The precursors of hematopoietic cells in BM undergo continuous proliferation and differentiation and are highly vulnerable to acute and chronic oxidative stress. Little is known about the oxidant and antioxidant status in the BM of untreated patients with nonhematologic tumors. In this study, oxidative stress was evaluated in peripheral blood plasma (PBP) and BM plasma (BMP) from lung carcinoma (LC) and breast carcinoma (BC) patients.
METHODS
The sample included 13 consecutive untreated LC patients, 15 BC patients, and 11 healthy controls. Luminol‐dependent chemiluminescence was used to evaluate oxygen radical generation by peripheral blood neutrophils. Lipid oxidation, assessed by 2‐thiobarbituric acid‐reactive substances (TBARS), and α‐tocopherol, β‐carotene, and total ubiquinol‐10 levels were determined in PBP and BMP.
RESULTS
In LC and BC patients, neutrophil chemiluminescence was higher (128% and 264%, respectively) than in controls (P < 0.05). In cancer patients, TBARS levels were higher in both PBP (51% and 243% for LC and BC patients, respectively) and BMP (66% and 305% for LC and BC patients, respectively) than in plasma from controls (P < 0.01). α‐Tocopherol and total ubiquinol‐10 levels were significantly lower in BMP from BC patients compared with controls. In BC patients, α‐tocopherol content in PBP was significantly lower than in controls.
CONCLUSIONS
Untreated cancer patients presented an imbalance between oxidant generation and lipid‐soluble antioxidant levels in favor of the former. Cancer 2002;94:3247–51. © 2002 American Cancer Society.
DOI 10.1002/cncr.10611
📜 SIMILAR VOLUMES
## Abstract Tumor tissues, blood plasma and bone marrow (BM) aspirates of 57 prostate cancer patients (PCa) without clinical signs of overt metastases were assessed for LOH (loss of heterozygosity) by a PCR‐based fluorescence microsatellite analysis, using a panel of 15 markers. Additionally, micro
Immunocytochemical detection (ICC) of isolated tumor cells in bone marrow (BM) is currently the most established method for monitoring early dissemination in epithelial cancer. However, the low sample size that can practically be analyzed restricts the sensitivity and reliability of the ICC method.